CAR-Macrophage for Cancer Immunotherapy: Latest Findings from the CT-0508 Clinical Trial

Carisma Therapeutics is currently running the first clinical trial evaluating engineered macrophages for patients with hard-to-treat solid tumors. Learn more about the power of this novel immunotherapy and how to enroll at www.carismatx.com.